Answer
Clariscan (gadoterate meglumine) is contraindicated in patients with hypersensitivity to the active substance or any excipient listed in section 6.1.
Sources for this answer
- Clariscan 0.5 mmol/ mL solution for injectionGE Healthcare Limited · emc · SmPC §4.3 Contraindications · Version 5Document updated
Sources checked